Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Healthcare Equipment & Supplies Breadcrumb chevron Biocept Inc
Biocept Inc logo

BIOC - Biocept Inc News Story

$4.6 -0.3  -5.2%

Last Trade - 09/04/21

Sector
Healthcare
RiskRating
Speculative
Size
Micro Cap
Style
Style Neutral
Market Cap £45.0m
Enterprise Value £36.3m
Revenue £20.0m
Position in Universe 5515th / 6827
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BIOC Dividends
All News

BRIEF-Biocept And Protean BioDiagnostics Establish Research Collaboration To Demonstrate Advantages Of Biocept’s Target Selector Assay Kit For Non-Small Cell Lung Cancer Patients

Biocept Inc News
Tue 23rd February, 2021 1:18pm
Feb 23 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT AND PROTEAN BIODIAGNOSTICS ESTABLISH RESEARCH
COLLABORATION TO DEMONSTRATE ADVANTAGES OF BIOCEPT’S TARGET
SELECTOR™ ASSAY KIT FOR NON-SMALL CELL LUNG CANCER PATIENTS

Source text for Eikon:  ID:nBw7qWZfBa 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biocept Inc

See all news
BUZZ-Biocept: Jumps on swing to Q4 profit after COVID-19 testing demand surges
30th Mar News
BRIEF-Biocept Reports 2020 Fourth Quarter And Full Year Financial Results
29th Mar News
BUZZ-Biocept: Rises on supply deal for COVID-19 test kit
2nd Mar News
BRIEF-Aegea Biotechnologies Announces Supply Agreement With Biocept For New Covid-19 Test
2nd Mar News
BRIEF-Biocept And Protean BioDiagnostics Establish Research Collaboration To Demonstrate Advantages Of Biocept’s Target Selector Assay Kit For Non-Small Cell Lung Cancer Patients
23rd Feb News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.